NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 308 filers reported holding NATERA INC in Q4 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $136,495,851 | -8.7% | 3,084,652 | +0.4% | 0.06% | -4.9% |
| Q2 2023 | $149,506,196 | +36.3% | 3,072,466 | +55.5% | 0.06% | +29.8% |
| Q1 2023 | $109,679,871 | +127.1% | 1,975,502 | +64.3% | 0.05% | +113.6% |
| Q4 2022 | $48,299,685 | +2082.5% | 1,202,382 | +2280.5% | 0.02% | +2100.0% |
| Q3 2022 | $2,213,000 | -57.3% | 50,509 | -65.5% | 0.00% | -50.0% |
| Q2 2022 | $5,183,000 | +156.1% | 146,246 | +193.9% | 0.00% | +100.0% |
| Q1 2022 | $2,024,000 | -57.1% | 49,755 | -1.5% | 0.00% | -50.0% |
| Q4 2021 | $4,719,000 | -20.0% | 50,533 | -4.5% | 0.00% | 0.0% |
| Q3 2021 | $5,898,000 | -30.9% | 52,926 | -29.6% | 0.00% | -33.3% |
| Q2 2021 | $8,531,000 | -40.8% | 75,147 | -47.0% | 0.00% | -50.0% |
| Q1 2021 | $14,410,000 | +1.4% | 141,917 | -0.6% | 0.01% | -14.3% |
| Q4 2020 | $14,213,000 | +37.8% | 142,817 | 0.0% | 0.01% | +16.7% |
| Q3 2020 | $10,317,000 | +31.6% | 142,817 | -9.1% | 0.01% | +20.0% |
| Q2 2020 | $7,837,000 | +239.6% | 157,180 | +103.3% | 0.01% | +150.0% |
| Q1 2020 | $2,308,000 | -9.8% | 77,300 | +1.7% | 0.00% | +100.0% |
| Q4 2019 | $2,560,000 | +3.4% | 76,000 | +0.7% | 0.00% | -50.0% |
| Q3 2019 | $2,476,000 | -54.4% | 75,500 | -61.6% | 0.00% | -33.3% |
| Q2 2019 | $5,426,000 | +641.3% | 196,726 | +454.2% | 0.00% | – |
| Q1 2019 | $732,000 | +31.7% | 35,500 | -10.8% | 0.00% | – |
| Q4 2018 | $556,000 | -43.4% | 39,800 | -2.9% | 0.00% | -100.0% |
| Q3 2018 | $982,000 | +36.6% | 41,000 | +7.3% | 0.00% | 0.0% |
| Q2 2018 | $719,000 | +116.6% | 38,200 | +6.7% | 0.00% | – |
| Q1 2018 | $332,000 | +11.4% | 35,800 | +8.2% | 0.00% | – |
| Q4 2017 | $298,000 | -30.2% | 33,100 | 0.0% | 0.00% | – |
| Q3 2017 | $427,000 | +18.9% | 33,100 | 0.0% | 0.00% | – |
| Q2 2017 | $359,000 | +52.1% | 33,100 | +24.4% | 0.00% | – |
| Q1 2017 | $236,000 | -20.0% | 26,600 | +5.6% | 0.00% | – |
| Q4 2016 | $295,000 | +5.4% | 25,200 | 0.0% | 0.00% | – |
| Q3 2016 | $280,000 | +1.1% | 25,200 | +9.6% | 0.00% | – |
| Q2 2016 | $277,000 | – | 23,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,104,581 | $48,403,000 | 19.54% |
| Kynam Capital Management, LP | 2,018,360 | $88,445,000 | 18.64% |
| Foresite Capital Management III, LLC | 159,160 | $6,974,000 | 18.41% |
| Sofinnova Investments, Inc. | 3,102,960 | $135,972,000 | 7.91% |
| Eagle Health Investments LP | 595,994 | $26,116,000 | 5.99% |
| Eversept Partners, LP | 1,425,602 | $62,469,880 | 5.41% |
| Lagoda Investment Management, L.P. | 159,220 | $6,977,000 | 4.96% |
| Hudson Executive Capital LP | 588,886 | $25,805,000 | 3.70% |
| Parian Global Management LP | 24,000 | $1,052,000 | 3.42% |
| BRANDYWINE MANAGERS, LLC | 21,534 | $944,000 | 3.10% |